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Pregnancy frequently has a beneﬁcial effect on the autoimmune disease Rheumatoid Arthritis, ranging
from improvement in clinical symptoms to complete remission. Despite decades of study, a mechanistic
explanation remains elusive. Here, we demonstrate that an analogous pregnancy-induced remission can
be observed in a mouse model of arthritis. We demonstrate that during pregnancy mice are protected
from collagen-induced arthritis, but are still capable of launching normal immune responses to inﬂuenza
infections. We examine the role of regulatory T (TR) cells in this beneﬁcial effect. TR cells are essential for
many aspects of immune tolerance, including the suppression of autoimmune responses. Remarkably,
transfer of regulatory T cells from pregnant ‘protected’ mice was sufﬁcient to confer protection to non-
pregnant mice. These results suggest that regulatory T cells are responsible for the pregnancy-induced
amelioration of arthritis.
 2011 Elsevier Ltd. Open access under CC BY license.1. Introduction
Rheumatoid Arthritis is an autoimmune disease predominantly
affecting post-menopausal women, but that can also affect women
of childbearing age [1]. As a consequence, clinicians are faced with
difﬁcult choices regarding the selection of an optimal therapeutic
regime that deals with the symptoms of the disease without
negatively affecting the pregnancy, as some of the therapeutic
regimes for RA are unsafe for use during pregnancy [2]. Further,
women with RA have an increased risk of adverse pregnancy
outcomes [3e5]. A better understanding of the mechanism driving
the pregnancy-associated changes in RA will provide us with valu-
able information to help resolve this problem. In addition, it will
provide useful clues regarding the pathogenesis of RA in general,
thus opening theway to the development of novel treatments [6,7].
Frequently, disease activity in patients with RA decreases spon-
taneously during pregnancy ranging from an improvement in
clinical symptoms to complete remission. However, this effect is
transient and the disease relapses shortly after delivery [8]. This
pregnancy-induced amelioration of RA symptoms was ﬁrstlatory T cells; CIA, collagen-
ular patterns.
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 license.described by Hench in 1938 [9] and was a crucial hint towards the
identiﬁcation of corticosteroids as immunosuppressive drugs for
use in treating autoimmunity (Table 1) [6]. Since then, a large
number of retrospective and prospective studies on RA patients
have conﬁrmed that an improvement in disease activity occurs
during pregnancy in half to three quarters of patients [8,10e12]. It is
noteworthy that the higher efﬁcacy of more recently developed
therapeutic regimes is thought to lead to lower levels of RA activity
in patients prior to pregnancy, thus partially “masking” the bene-
ﬁcial effect of pregnancy inmore recent reports [7]. Despite decades
of study, a mechanistic explanation for the pregnancy-induced
remission and post-partum relapse of RA remains elusive [12].
Here, we examine the role of CD25þ regulatory T (TR) cells in this
beneﬁcial effect. TR cells are a naturally occurring subpopulation of
T cells that are essential for many aspects of immune tolerance,
including the suppression of autoimmune responses [13]. During
pregnancy they protect the fetus from rejection by the maternal
immune system in both mice [14] and humans [15e17] (Table 2).
The accumulation of antigen-experienced TR cells in the uterus [18]
suggests that the suppression of the anti-fetal immune response
occurs in a localized and antigen-speciﬁc fashion. Further support
for an antigen-speciﬁc action of TR cells comes from studies
examining the immune response to the minor transplantation
antigen H-Y in the context of maternalefetal tolerance [19]. A hint
regarding an involvement of TR cells in the amelioration of RA
comes from the observation that their number inversely correlates
with disease activity during pregnancy [20] (Table 1). However,
experimental proof for a mechanistic involvement of TR cells
remained outstanding.
Table 1
Mechanism implicated in the pregnancy-associated amelioration of arthritis.
Human studies Mouse studies Comment
The immune-modulatory action of corticosteroids was
suspected to improve RA during pregnancy [6]
This has subsequently been shown
not to be relevant in this context [6]
TH2 shift during pregnancy might redirect the immune
response [43e45]
There is no essential role for TH2-associated
cytokines in maternalefetal tolerance [47]
Prolactin [25] is associated with the post-partum
relapse of symptoms, whilst oestrogen appears
to have the opposite effect [26]
The kinetics of hormonal changes after
delivery does not match that of the relapse
of symptoms [10]
IgG-associated agalactosyl falls during pregnancy in patients
and is inversely correlated to disease severity [27]
The mechanism of this observation
remains to be elucidated [28]
MHC disparity between mother and fetus is correlated
to the amelioration of RA during pregnancy [32,33]
Allogeneic pregnancy is associated with
increased amelioration of arthritis [30,31]
Extensive data, though some
is conﬂicting [35]
Correlation between the number of TR cells and the
pregnancy-induced amelioration of RA [20]
A. Munoz-Suano et al. / Journal of Autoimmunity 38 (2012) J103eJ108J104To examine whether TR cells mediate the pregnancy-associated
remission of arthritis, we studied the phenomenon in Collagen-
Induced Arthritis (CIA), a mouse model of the disease. We found
that pregnancy protects the mice from developing arthritis.
Transfer of CD25þ cells from these pregnant-protected mice into
non-pregnant recipients protected them from CIA. The fact that
transfer of CD25þ cells from pregnant mice that were not exposed
to CIA induction did not confer protection to the recipients suggests
that the TR cells act in an antigen-speciﬁc fashion.
2. Materials and methods
2.1. Animal care
All animal care was provided by expert animal technicians, in
compliance with the relevant laws and institutional guidelines.
2.2. Inﬂuenza infections
C57BL/6 females and C57BL/6 females mated with BALB/c males
were infected intra-nasally with 104 PFU of HKx31(H3N2) virus [21]
under iso-ﬂuorane anesthesia on the ﬁrst day of pregnancy (as
determined by detection of a vaginal plug). On day 10 after infec-
tion antigen-speciﬁc cells were identiﬁed using PE and APC
conjugated H-2Db/NP ASNENMETM pentamers (Proimmune) and
anti-mouse CD8 FITC (eBioscience, clone 53e6.7) by FACS.
2.3. Collagen-induced arthritis
Female C57BL/6 mice received an intra-dermal injection of
100 ml of 100 mg chicken collagen type II (Sigma) in CompleteTable 2
The role of TR cells in pregnancy and arthritis.
Human studies Mouse studies
TR cells are associated with
maternalefetal tolerance
[15e17]
TR cells are necessary for maternalefetal
tolerance [14]
TR cell-mediated maternalefetal tolerance
is antigen-speciﬁc [18,19]
TR cells defective in RA
patients [37]
Ablation/depletion of TR cells exacerbates
arthritis [36,38,50]
Adoptive transfer of polyclonal pre-stimulat
cells can reduce signs of arthritis [51,52]
iFoxp3-transduced cells can be induced to a
cell phenotype and prevent arthritis in an
antigen-speciﬁc fashion [42]
Danger signals break TR cell-mediated toleraFreund’s Adjuvant, on day 0 and day 21 and were monitored for
clinical signs of CIA on a daily basis. The humane endpoint for this
series of experiments was set when the mice reached a clinical
score [22] of 8 out of 12. Some of the mice were set up for mating
with BALB/c males from day 31e35 (one estrus cycle). All mice that
reached a clinical score above 6 prior to the day of the set up of
matings were excluded from the experiment, irrespective of
whether they partook in matings or not.
2.4. Cell puriﬁcations
Cell suspensions of spleen, lymph nodes and uterus were
prepared by gently forcing the tissues through 70 mm-pore cell
strainers. Lymphocytes were isolated by Lympholyte (Cedarlane)
gradient centrifugation according to manufacturer’s instructions,
pooled and stained with anti-mouse CD25-PE antibody (clone 7D4,
BD). After incubation with anti-PE beads (Miltenyi Biotec) the cells
were isolated using MS columns (Miltenyi Biotec) according to
manufacturers instructions and the purity assessed by FACS. Cells
were re-suspended in PBS and intravenously injected into mice.
2.5. Adoptive transfer
The experimental designs are outlined in Figs. 1 and 3. CIA-
induced C57BL/6 females received an adoptive transfer of CD25þ
cells 31 days after the start of CIA induction. The cells used were
prepared from C57BL/6 females that were treated to induce CIA,
mated and sacriﬁced on day 9.5e11.5 of gestation (pregnant-pro-
tected), or did not receive any CIA induction but were mated and
sacriﬁced at the same time (pregnant), or were neither treated to
induce CIA nor mated (non-pregnant). For 1:1 transfers all CD25þComments
These studies indicate that TR cells are involved in the
regulation of RA associated immune responses.
ed TR Adoptive transfer of non-activated polyclonal TR cells
has no effect on arthritis [53]
ssume TR This ‘Trojan horse’ approach circumvents the requirement
of pre-activation of the cells and makes the suppression
antigen-speciﬁc
nce [48] Some pathogens can exploit the TR cell-mediated
pregnancy-induced reassessment of immune status [49]
d 21d 0
7 4 21 20 1 8 35 42time [days]
d 31 to d 35
Fig. 1. Timeline of CIA inductions and matings. CIA was induced by intra-dermal injection of C57BL/6 mice with chicken collagen type II in Complete Freund’s Adjuvant (syringe) on
day 0 and day 21. The mice were set up to mate with allogeneic BALB/c males from day 31 to day 35 (hearts).
A. Munoz-Suano et al. / Journal of Autoimmunity 38 (2012) J103eJ108 J105cells from one donor were adoptively transferred into one recip-
ient, irrespective of the cell number. As our emphasis was to
minimize loss of TR cells during puriﬁcation, we followed a protocol
optimized for high yield of CD25þ cells, typically achieving >50%
purity. None of the pregnant-protected mice used as donors
showed any signs of arthritis (in all cases the clinical score was<3).2.6. Statistical analyses
Statistical analyses were performed using GraphPad Prism and
Excel as appropriate.3. Results
CIA in mice resembles the pathology of RA both in terms of
histopathology and serological biomarkers [22,23]. To induce
arthritis in C57BL/6 mice we injected them with chicken Collagen
Type II in Complete Freund’s Adjuvant intra-dermally on day 0 and
day 21. Some of the mice were mated allogeneically with BALB/c
males on days 31e35 (Fig. 1). We compared the course of CIA in
non-pregnant (n ¼ 111) and pregnant (n ¼ 44) mice and found that
pregnancy protected the mice from the disease (incidence of 32%
vs. 11%; Table 3). This is reﬂected in both the average clinical score
over time (P ¼ 0.0002, two-tailed Wilcoxon signed rank test;
Fig. 2A) and the maximum clinical score reached (Fig. 2B).
To verify that this is not due to a pregnancy-induced systemic
immunosuppression, we compared the response to intra-nasal
inﬂuenza HKx/31(H3N2) infection in pregnant (n ¼ 5) and non-
pregnant mice (n ¼ 9). We found that pregnancy had no effect on
the expansion of CD8þ cells speciﬁc for the He2Db/nucleoprotein
(NP) peptide complex (non-pregnant vs. pregnant; 7.44  0.65 vs.
7.48  0.51; P ¼ 1, two-tailed unpaired t-test; Fig. 2C and Table 4).
This demonstrates that pregnant mice are capable of launching
normal immune responses against this pathogen. Thus, the
protection from arthritis cannot be due to a pregnancy-induced
systemic immune suppression.
To investigate whether the protection from CIA during preg-
nancy can be attributed to the action of TR cells, we ‘substituted’
pregnancy with adoptive transfer of CD25þ cells (Fig. 3). Non-
pregnant mice, in which CIA had been induced, received CD25þ
cells sourced from either non-pregnant control mice (non-preg-
nant; n ¼ 21), untreated pregnant mice (pregnant; n ¼ 19), or mice
that were protected from the disease by pregnancy despite CIA
induction (pregnant-protected; n ¼ 5). Each recipient mouse
received all CD25þ cells obtained from a donor mouse in a one-to-
one fashion. Whilst none of the mice receiving CD25þ cells from
pregnant-protected donors developed arthritis, 24% (5 out of 21) ofTable 3
Amelioration of CIA during pregnancy.
Status of animal No. of mice Incidence
Non-pregnant 111 35/111 (32%)
Pregnant 44 5/44 (11%)
Results show the total number of individual mice in 7 independent experiments.recipients of cells from non-pregnant donors and 32% (6 out of 19)
of the recipients of cells from pregnant untreated donors developed
arthritis (Fig. 4A; 1:1 transfer).
The number of CD4þCD25þ cells signiﬁcantly increases during
pregnancy from 0.35 to 0.5  106 cells in non-pregnant mice to
approx. 1.5  106 cells in pregnant mice [14]. Therefore, we titrated
the number of cells transferred to match the numbers that can be
obtained from non-pregnant donors. Transfer of 0.35  106 CD25þ
cells from control mice had no effect on the outcome of CIA in the
recipients (no transfer vs. non-pregnant; Table 5 and Fig. 4B).
Whilst transfer of the same number of CD25þ cells from pregnant
mice appeared to cause a slight delay in the onset of clinical signs
(pregnant, Fig. 4B), the outcome per sewas not affected (no transfer
vs pregnant; Table 5). In contrast, none of the recipients of CD25þ
cells from pregnant-protected mice developed any signs of arthritis
(pregnant-protected, Fig. 4B and Table 5).
In summary, we observed a signiﬁcant protection from CIA
(pregnant-protected, P < 0.05, two-tailed Fischer’s exact test;
Fig. 4A) irrespective of the number of cells transferred and conclude
that TR cells mediate the pregnancy-associated protection from CIA.
The fact that TR cells from pregnant mice that did not undergo CIA
induction did not protect from arthritis (non-pregnant vs. preg-
nant; Table 6 and Fig. 4A) shows that the pregnancy by itself is
insufﬁcient to protect from arthritis. Rather, our data suggest that
this protective effect requires prior exposure of the TR cells to
arthritis-related antigens in the context of pregnancy (non-preg-
nant vs. pregnant-protected; Table 6 and Fig. 4A).4. Discussion
Since the ﬁrst description of the pregnancy-induced ameliora-
tion of RA symptoms, numerous studies have attempted to eluci-
date the underlying mechanism (Table 1). Pioneering work by
Whyte and co-workers used a model of CIA in DBAmice to examine
both the amelioration of arthritis during pregnancy and the post-
partum relapse of the disease [24]. Their results suggested that
prolactin [25] and oestradiol [26] have opposite effects on the post-
partum course of the disease. Yet, due to the lack of precise
temporal correlation with disease activity, doubts were expressed
on the role of hormones in this process [10]. A better temporal
correlationwith disease activity was observed for the percentage of
IgG-associated agalactosyl N-linked oligosaccharides, which
decreases during the amelioration of arthritis [27]. However, this
could not be explained by a pregnancy-induced clearance of the
agalactosyl IgG by mannose-binding lectin [28].
A further line of investigation centered on the observation that
allogeneically mated B10.RIII females were more protected from
CIA than syngeneicallymated females [29]. This has been attributed
to both changes in the ratio of Tcell populations [30] and changes in
cytokine levels [31]. In humans, the extent of disparity in HLA-DP
and HLA-DQ MHC Class II molecules between the mother and the
fetus was found to correlate with remission from arthritis during
pregnancy [32e34], though a later study on inﬂammatory poly-
arthritis did not ﬁnd such a correlation [35].
Several lines of evidence have suggested that TR cells have a role
in the regulation of arthritis [36]. TR cells in RA patients show
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Fig. 2. Pregnancy protects from CIA. (A) Time course (days after CIA induction) of the average severity (P ¼ 0.0002, two-tailed Wilcoxon signed rank test) or (B) the maximum
severity reached (P ¼ 0.0136, two-tailed Fisher’s exact test for score <3 versus score 3). (C) Percentage of NP-pentamerþ CD8þ cells in the spleen 10d after intra-nasal HKx31
inﬂuenza infection on the ﬁrst day of pregnancy (non-pregnant: n ¼ 9; pregnant: n ¼ 5; P ¼ 1, two-tailed unpaired t-test). Error-bars represent the standard error of the mean.
Table 4
Response to inﬂuenza infection.
Status of animal No. of mice PentamerþCD8þ cells [%]
Non-pregnant 9 7.44  0.65 (SEM)
Pregnant 5 7.48  0.51 (SEM)
Results are represented as percentage of antigen-speciﬁc CD8þ cells  SEM.
A. Munoz-Suano et al. / Journal of Autoimmunity 38 (2012) J103eJ108J106functional defects [37] and depletion of TR cells in mice leads to
increased disease severity [38]. Here, we demonstrate that TR cells
from pregnant-protected mice are sufﬁcient to confer protection
from CIA when transferred into non-pregnant mice. This strongly
suggests that TR cells are responsible for the pregnancy-induced
amelioration of RA.
Prior to pregnancy, exposure of the mother to paternal trans-
plantation antigens induces a rigorous immune response against
the graft [39]. In the context of pregnancy, this response is sup-
pressed to prevent a rejection of the fetus [14]. It appears that some
autoimmune responses such as rheumatoid arthritis and multiple
sclerosis [40] are also re-assessed during pregnancy, resulting in
a temporary amelioration of these diseases.-35-42 -28 -21
d -31
d -31
d -31
d -31
(i)   no transfer
(ii)   TR cells from
        non-pregnant
(iii)   TR cells from
        pregnant
(iv)   TR cells from
        pregnant
        protected
time [days]
d -21d -42
Fig. 3. Timeline of CIA inductions and adoptive transfer of TR cells. Donors are shown in grey
(i) received no TR cell graft (no transfer), (ii) received TR cells isolated from non-pregnant don
(iv) received TR cells isolated from donors that were protected from the disease by pregn
inductions (syringe), matings (heart) and adoptive transfers (IV (TR)) are shown on the timAutoimmune responses could potentially be suppressed in an
antigen-speciﬁc fashion or by bystander effects. The accumulation of
antigen-experienced TR cells in the gravid uterus [18] suggests that
the suppression of the anti-fetal immune response occurs in a local-
ized and antigen-speciﬁc fashion (see also Table 2). Similarly, in the
case of autoimmune diabetes, the data points to a highly antigen-
speciﬁc involvement of TR cells [41]. Further support for an antigen-
speciﬁc action of TR cell comes from our endeavours to ﬁnd a cell-
mediated therapy for arthritis. Genetically engineered inducible
Foxp3 (iFoxp3) canbeused to confer TR cell phenotype toTH cells [42].
This can beused to stop CIAusing iFoxp3-transduced, polyclonal Tcell
autografts. We found that this approach only worked if the iFoxp3-
transduced TH cells were exposed to arthritis antigens prior to
switching on Foxp3 [42]. If iFoxp3 was switched on prior to exposure
to arthritis antigens, the course of the disease was not affected. All
these ﬁndings point towards an antigen-speciﬁc suppression by TR
cells. The data presented here provide evidence that the amelioration
of arthritis during pregnancy is also antigen-speciﬁc. Only TR cells
isolated from ‘pregnant-protected’mice conferredarthritis protection
to non-pregnant mice. TR cells from pregnant mice that had not been
exposed to arthritis-related antigens could not confer protection.-14 -7 0 7 14
d -10 d 18
d -10 d 18
d -10 d 18
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Fig. 4. Regulatory T cells mediate pregnancy-induced protection from arthritis. The effect of adoptive transfer of CD25þ cells prepared from either non-pregnant, pregnant or ‘CIA-
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Table 5
Clinical features of CIA after transfer of 0.35  106 CD25þ cells.
Type of donor No. of mice Incidence
no transfer 15 3/15 (20%)
non-pregnant 11 4/11 (36%)
pregnant 7 2/7 (29%)
pregnant-protected 10 0/10 (0%)
Results show the total number of individual mice in 3 independent experiments.
A. Munoz-Suano et al. / Journal of Autoimmunity 38 (2012) J103eJ108 J107Some mechanistic insight comes from the observation that
pregnancy is accompanied by a shift from TH1 to TH2 type
responses. It has been suggested that this in itself might lead to
a diminution of the underlying immune response driving RA
[43,44]. Pregnant women with RA display a reduction in the
capacity of their peripheral blood mononuclear cells to produce the
TH1 cytokines IL-12 and IFNg [45]. This hypothesis could explain
why some autoimmune diseases such as SLE can exhibit ﬂares
during pregnancy, presumably due to a TH2 bias of the underlying
immune response [46]. It remains to be seen whether the TH1/TH2
shift during pregnancy acts in parallel to the action of TR cells or
whether the change in bias is actually mediated by the TR cells. It is
noteworthy that in contrast to the essential requirement for TR
cells, a change in the TH1/TH2 bias is not fundamental to mater-
nalefetal tolerance, as mice deﬁcient in TH2 cytokines can become
allogeneically pregnant [47].
We propose that the amelioration of arthritis is a collateral
consequence of the immune system’s reassessment of all responses
coinciding with pregnancy. By making context-dependent deci-
sions, the immune system can suppress immune responses
directed against the fetus whilst remaining vigilant towardsTable 6
Clinical features of CIA after transfer of CD25þ cells, irrespective of the number of
cells transferred.
Type of donor No. of mice Incidence
non-pregnant 21 5/21 (24%)
pregnant 42 10/42 (24%)
pregnant-protected 21 0/21 (0%)
Results show the total number of individual mice in 6 independent experiments.pathogens, such as inﬂuenza, that are recognized to be a danger to
the mother. The ﬁnding that pathogen-associated molecular
patterns (PAMPs) under certain, speciﬁc conditions can block TR-
mediated suppression [48] offers a hint to as to how the immune
system might interpret the context. The absence of exogenous
‘danger’ signals in ongoing autoimmune responses might be sufﬁ-
cient for the immune system during pregnancy to reassess and
suppress them. Onemight speculate that the transient nature of the
pregnancy-associated suppression is of evolutionary advantage, as
a more permanent induction of tolerance would be prone to be
exploited by pathogens. Indeed, certain pathogens, such as Listeria
and Salmonella, appear to be able to take advantage of the
pregnancy-induced tolerance mechanisms, as these infections are
exacerbated by pregnancy [49]. The exact mechanism by which
immune responses coinciding with pregnancy are re-interpreted
by the immune system warrants further investigation.
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